EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Challenges and Opportunities of Photodynamic Therapy against Cancer

Ruben V Huis In 't Veld, Jeroen Heuts, Sen Ma iD, Luis J Cruz, Ferry A Ossendorp, Martine J Jager iD

Pharmaceutics · 18.01.2023 · 15 (2) · 330

DOI: 10.3390/pharmaceutics15020330 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 18.01.2023. Verfasst von Ruben V Huis In 't Veld und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Leiden University Medical Centre (LUMC), 2333 ZA Leiden, Zuid-Holland, The Netherlands. Die Arbeit wurde bisher 155-mal zitiert (Crossref) und nennt 332 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Holland, Health-Holland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Photodynamic therapy (PDT) is an established, minimally invasive treatment for specific types of cancer. During PDT, reactive oxygen species (ROS) are generated that ultimately induce cell death and disruption of the tumor area. Moreover, PDT can result in damage to the tumor vasculature and induce the release and/or exposure of damage-associated molecular patterns (DAMPs) that may initiate an antitumor immune response. However, there are currently several challenges of PDT that limit its widespread application for certain indications in the clinic. METHODS: A literature study was conducted to comprehensively discuss these challenges and to identify opportunities for improvement. RESULTS: The most notable challenges of PDT and opportunities to improve them have been identified and discussed. CONCLUSIONS: The recent efforts to improve the current challenges of PDT are promising, most notably those that focus on enhancing immune responses initiated by the treatment. The application of these improvements has the potential to enhance the antitumor efficacy of PDT, thereby broadening its potential application in the clinic.

Schlagwörter

Stichwörter der Autor:innen

cancerdamage-associated molecular patternsimmunogenic cell deathphotodynamic therapyphotoimmunotherapyreactive oxygen species

Autor:innen und Institutionen

  • Department of Ophthalmology, Leiden University Medical Centre (LUMC), 2333 ZA Leiden, Zuid-Holland, The Netherlands.
  • Department of Radiology, Leiden University Medical Centre (LUMC), 2333 ZA Leiden, Zuid-Holland, The Netherlands.
  • Department of Immunology, Leiden University Medical Centre (LUMC), 2333 ZA Leiden, Zuid-Holland, The Netherlands.

ORCID-Profile: Sen Ma, Martine J Jager

Förderung

  • Health Holland
  • Health-Holland

Zitieren

APA

Huis In 't Veld, R. V., Heuts, J., Ma, S., Cruz, L. J., Ossendorp, F. A., & Jager, M. J. (2023). Current Challenges and Opportunities of Photodynamic Therapy against Cancer. Pharmaceutics, 15(2), 330. https://doi.org/10.3390/pharmaceutics15020330

Vancouver

Huis In 't Veld RV, Heuts J, Ma S, Cruz LJ, Ossendorp FA, Jager MJ. Current Challenges and Opportunities of Photodynamic Therapy against Cancer. Pharmaceutics. 2023;15(2):330. doi:10.3390/pharmaceutics15020330

BibTeX
@article{HuisIntVeld2023,
  author = {Huis In 't Veld, Ruben V and Heuts, Jeroen and Ma, Sen and Cruz, Luis J and Ossendorp, Ferry A and Jager, Martine J},
  title = {Current Challenges and Opportunities of Photodynamic Therapy against Cancer},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {2},
  pages = {330},
  doi = {10.3390/pharmaceutics15020330}
}
Kostenlos starten →